CalciMedica is trading at $1.36, up 10.56%, with no clear company-specific catalyst reported for the October 26 rise.

  • The reported CFO transition is dated October 16.
  • Broader indexes also gained more than 0.5%, pointing to supportive market sentiment but not a confirmed direct cause.
  • Shares had risen in recent sessions, closing at $1.23 on October 23 after a 6.96% gain.